Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Genetics
  • Page 11
cytiva-expands-collaboration-with-culture-biosciences
Posted inGenetics

Cytiva Expands Collaboration with Culture Biosciences

August 6, 2025
Credit: Culture Biosciences Cytiva expanded its collaboration with Culture Biosciences, which specializes in cloud-connected bioreactor technology, to include both hardware…
Read More
rna-splicing-mechanism-opens-path-to-treat-diabetes
Posted inGenetics

RNA Splicing Mechanism Opens Path to Treat Diabetes

August 6, 2025
Type-II diabetes is a chronic disease caused by insulin resistance due to pancreatic β-cell dysfunction. Mutations in a single gene,…
Read More
out-of-thin-air:-hypoxia-reverses-parkinson’s-symptoms-in-mice
Posted inGenetics

Out of Thin Air: Hypoxia Reverses Parkinson’s Symptoms in Mice

August 6, 2025
Parkinson’s disease (PD) is the second-most common neurodegenerative disorder after Alzheimer’s and is caused by the degeneration of dopamine-producing neurons…
Read More
nanoparticles-slow-disease-progression-and-reduce-flare-severity-in-ra-mouse-model
Posted inGenetics

Nanoparticles Slow Disease Progression and Reduce Flare Severity in RA Mouse Model

August 6, 2025
Rheumatoid arthritis (RA) is a chronic, incurable disorder, so treatment focuses on managing the disease and controlling its progression. Although…
Read More
Posted inGenetics

Immune-Independent Bacterial Therapy Destroys Tumors in Mice

August 6, 2025
Over a century ago, William B. Coley, MD, famously injected cancer patients with bacterial toxins in a bold attempt to…
Read More
3-blas-in-3-years:-ocugen-sees-potential-in-eye-disease-gene-therapies
Posted inGenetics

3 BLAs in 3 Years: Ocugen Sees Potential in Eye Disease Gene Therapies

August 5, 2025
Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three…
Read More
cho-plus-signs-two-mab-production-deals,-joins-2025-biotools-accelerator
Posted inGenetics

CHO Plus Signs Two mAb Production Deals, Joins 2025 BioTools Accelerator

August 5, 2025
CHO Plus was awarded a project agreement from the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium…
Read More
glp-1-drug-semaglutide-linked-to-reduced-muscle-strength-in-mice
Posted inGenetics

GLP-1 Drug Semaglutide Linked to Reduced Muscle Strength in Mice

August 5, 2025
GLP-1 receptor agonists have transformed obesity and diabetes care by helping millions shed excess weight—but new mouse research suggests the…
Read More
addressing-malaria-resistance-with-ai,-open-science,-and-next-gen-therapeutics
Posted inGenetics

Addressing Malaria Resistance with AI, Open Science, and Next-Gen Therapeutics

August 5, 2025
Gang Liu, PhD Senior Program OfficerGates Foundation Panelist Gang Liu, PhD Gang Liu is a Senior Program Officer at the…
Read More
genetic-variants-linked-to-frailty-unlock-aging-related-therapies
Posted inGenetics

Genetic Variants Linked to Frailty Unlock Aging-Related Therapies

August 5, 2025
Aging is a highly complex process with substantial heterogeneity in health trajectories between individuals. Frailty is a condition in which…
Read More

Posts pagination

Previous page 1 … 9 10 11 12 13 … 115 Next page

Privacy Policy    Terms

Scroll to Top